Showing 1 - 8 results of 8 for search 'T. Abuasab', query time: 0.12s Refine Results
  1. 1
    Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
    by Abuasab T, Rowe J, Tvito A
    Published 2021-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P497: PROGNOSTIC IMPACT OF RAS AND C-KIT MUTATIONS (SINGLE VS. MULTIPLE) IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA TREATED WITH FLUDARABINE, CYTARABINE, G-CSF (FLAG) BASED REGIMEN
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN COMBINATION WITH QUIZARTINIB FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH FLT3 OR CBL MUTATION
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    P496: CLINICAL CHARACTERISTICS OF SECONDARY MYELOID NEOPLASMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Myeloid lineage switch in <i>KMT2A-</i>rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS UNFIT FOR CHEMOTHERAPY
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    P541: OUTCOMES AND MANAGEMENT OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PRESENTING WITH HYPERLEUKOCYTOSIS
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE
    Get full text
    Article
    Save to List
    Saved in:
Search Tools: RSS Feed – Email Search